People: Alnylam Pharmaceuticals Inc (ALNY.O)
29 Mar 2017
Dr. John M. Maraganore, Ph.D., is Chief Executive Officer, Director of the Company. Dr. Maraganore also served as our President from December 2002 to December 2007. From April 2000 to December 2002, Dr. Maraganore served as Senior Vice President, Strategic Product Development at Millennium Pharmaceuticals, Inc., a biopharmaceutical company (now Millennium: The Takeda Oncology Company). Dr. Maraganore serves as the chairman of the board of directors of Agios Pharmaceuticals, Inc., a biotechnology company and as a member of the board of directors of bluebird bio, Inc., a biotechnology company.
|Total Annual Compensation, USD||1,112,030|
|Restricted Stock Awards, USD||--|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||632,810|
|Fiscal Year Total, USD||1,744,840|